2013•Journal of the Neurological SciencesRequires access

Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation

Paulo José Lorenzoni, Rosana Hermínia Scola, Cláudia Suemi Kamoi Kay, Luciane Filla, Anna P.P. Miranda, Joao Pinheiro, Amina Chaouch, Hanns Lochmüller, Lineu César Werneck

Open publisher page 53 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Congenital myasthenic syndrome, Salbutamol, Medicine, Pediatrics, Mutation, Genetics, Internal medicine, Biology

Back to paper search Browse research topics Original source

Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation — Research Paper | ScholarLens